Tevogen Bio Holdings (TVGN) Equity Ratio (2021 - 2026)
Tevogen Bio Holdings (TVGN) reported Equity Ratio of 2.0 for Q1 2026, down 5.52% on a YoY basis from 2.12 in Q1 2025, and down 6.45% quarter-over-quarter from 1.88 in Q4 2025.
Tevogen Bio Holdings (TVGN) Equity Ratio (2021 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported Equity Ratio for 6 years, with the latest figure at 2.0 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio fell 5.52% year-over-year to 2.0; the trailing twelve-month figure through Mar 2026 stood at 2.0 (down 5.52% YoY), and the FY2025 full-year result was 1.88, up 2.55% from the prior year.
- Equity Ratio for Q1 2026 stood at 2.0, down from 1.88 in the prior quarter.
- The five-year high for Equity Ratio was 0.04 in Q2 2022, with the low at 17.15 in Q4 2023.
- Historically, Equity Ratio has averaged 2.58 across 5 years, with a median of 1.9 in 2025.
- Annual changes were most pronounced in 2023 — Equity Ratio tumbled 17942.18% — and 2024, when it soared 88.76%.
- Tevogen Bio Holdings' Equity Ratio stood at 0.1 in 2022, then plunged by 17942.18% to 17.15 in 2023, then soared by 88.76% to 1.93 in 2024, then gained by 2.55% to 1.88 in 2025, then dropped by 6.45% to 2.0 in 2026.
- The last three Equity Ratio figures came in at 2.0 (Q1 2026), 1.88 (Q4 2025), and 1.74 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 191.07 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 0.98 |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 0.04 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.58 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 0.42 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 0.73 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 0.79 |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - | -2.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.00 |
| Dec 31, 2025 | -1.88 |
| Sep 30, 2025 | -1.74 |
| Jun 30, 2025 | -2.22 |
| Mar 31, 2025 | -1.90 |
| Dec 31, 2024 | -1.93 |
| Sep 30, 2024 | -1.44 |
| Jun 30, 2024 | -2.32 |
| Mar 31, 2024 | -1.73 |
| Dec 31, 2023 | -17.15 |
| Sep 30, 2023 | -3.44 |
| Jun 30, 2023 | -3.29 |
| Mar 31, 2023 | -2.54 |
| Dec 31, 2022 | -0.10 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | -0.04 |
| Mar 31, 2022 | -0.04 |
| Dec 31, 2021 | -0.04 |